Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT2080220798
JPRN-jRCT2080220798
Unknown
Phase 2

DU-176b Phase IIb clinical study (venous thromboembolism): Japan-Taiwan multicenter randomized double-blind dose-finding study using Enoxaparin as a reference in patients undergoing total hip replacement

DAIICHISANKYO Co.,Ltd.0 sites210 target enrollmentAugust 5, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients undergoing total hip arthroplasty

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Patients undergoing total hip arthroplasty
Sponsor
DAIICHISANKYO Co.,Ltd.
Enrollment
210
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2009
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
DAIICHISANKYO Co.,Ltd.

Eligibility Criteria

Inclusion Criteria

  • •Patients undergoing unilateral total hip arthroplasty
  • •Patients who are 20\-84 years olds

Exclusion Criteria

  • •Subjects with risks of hemorrhage
  • •Subjects with thromboembolic risks
  • •Subjects who weigh less than 40 kg
  • •Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 3
DU-176b Phase III Clinical Study (Venous Thromboembolism) Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Hip Arthroplasty with Enoxaparin as an Active Control
JPRN-jRCT2080220743DAIICHISANKYO Co.,Ltd.600
Unknown
Phase 3
DU-176b Phase III Clinical Study (Venous Thromboembolism) -A multicenter, Randomized, Unblinded Study of DU-176b in Patients Undergoing Hip Fracture Surgery with Enoxaparin as a referencePatients undergoing hip fracture surgery
JPRN-jRCT2080220770DAIICHISANKYO Co.,Ltd.90
Unknown
Phase 2
DU-176b Phase IIb Clinical Study (Deep Vein Thrombosis)
JPRN-jRCT2080220278DAIICHISANKYO Co.,Ltd.500
Unknown
Phase 3
DU-176b Phase 3 Clinical Study (Venous Thromboembolism) -Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Knee Arthroplasty with Enoxaparin as an Active Control
JPRN-jRCT2080220701DAIICHISANKYO Co.,Ltd.520
Unknown
Phase 2
Phase III Clinical Study of DU-176b (non-valvular atrial fibrillation): Japanese, Multicenter, Open-label Study of DU-176b in Patients with non-valvular atrial fibrillation and Severe Renal Impairmenton-valvular atrial fibrillation
JPRN-jRCT2080221674DAIICHI SANKYO Co.,Ltd.90